Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
08/2010
08/17/2010US7777069 Prodrugs of carbamate inhibitors of IMPDH
08/17/2010US7777057 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
08/17/2010US7777041 N-(4-(5-Butyl-2-methoxyphenyl)-1,3-thiazol-2-yl)-4-((4-oxopiperidin-1-yl)carbonyl)benzamide; antiinflammatory, anticarcinogenic, antidiabetic, analgesic agents
08/17/2010US7776902 N-[4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenylsulfonyl]-4-nitrooxybutanamide, used for the treatment of inflammatory, cardiovascular, gastrointestinal, respiratory and nervous system disorders, as analgesics, antipyretics and antocoagulants or for organ and tissue preservation
08/17/2010US7776898 Opioid receptor active compounds
08/17/2010US7776895 Inhalation devices for delivering phenethanolamine derivatives for the treatment of respiratory diseases
08/17/2010US7776890 1H-indazole compounds
08/17/2010US7776868 e.g. 6-[(1E)-2-(3,4-dimethoxyphenyl)vinyl]-3-ethyl-1,5-dimethyl-1,3-dihydrothiopheno[2,3-d]pyrimidine-2,4-dione; neurodegenerative disorders, antiischemic agent, antidepressant, attention deficit disorder, hepatic fibrosis, cirrhosis of the liver, and drug addiction
08/17/2010US7776829 lupus; for patients who are refractory or intractable to corticosteroid treatment, and treatment with cyclophosphamide, azathioprine, mycophenolate mofetil, anti-thymocyte-globin, methotrexate and immunoglobulin
08/17/2010US7776541 Psoriasin expression by breast epithelial cells
08/17/2010US7776342 Preparations that potentiate immunogenicity in low immunogenic antigens
08/17/2010US7776340 has a low level of homology to the enteric canine coronavirus, but which has a high level of homology to all bovine coronavirus strains (eg Quebec and LY138) and human coronavirus strain OC43
08/17/2010US7775469 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent
08/17/2010CA2552766C N-hydroxy-4- {5- [4- (5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy} benzamidine bis(methanesulfonate)
08/17/2010CA2547591C Novel compounds and compositions as cathepsin inhibitors
08/17/2010CA2530216C The use of an edible acid or the potassium or sodium salt thereof in the treatment of allergy
08/17/2010CA2481535C Use of ep4 receptor ligands in the treatment of il-6 involved diseases
08/17/2010CA2471762C Cell-permeable peptide inhibitors of the jnk signal transduction pathway
08/17/2010CA2461963C Cyclic amine compounds
08/17/2010CA2461212C Diaryl sulfide derivatives, salts thereof and immunosuppressive agents using the same
08/17/2010CA2444867C Combination comprising n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent
08/17/2010CA2411436C A method for detecting protein inhibitors and ligands
08/17/2010CA2385269C Novel thiazolo(4,5-d)pyrimidine compounds
08/17/2010CA2352563C Method to produce inactivated w/o emulsion adjuvanted vaccines
08/17/2010CA2337828C Phosphinic and phosphonic acid derivatives used as pharmaceuticals
08/17/2010CA2302522C Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as excipient
08/17/2010CA2203679C Oral immunization with transgenic plants
08/17/2010CA2144527C Up-converting reporters for biological and other assays using laser excitation techniques
08/12/2010WO2010090875A1 Derivatives of n2-(3-pyridil or phenyl)-n4-(4-piperidyl)-2,4-pyrimidinediamine useful in the treatment of inflammatory, autoimmune or proliferative diseases
08/12/2010WO2010090873A2 Polypeptides and their use as adjuvants
08/12/2010WO2010090407A2 A composition comprising an extract of puerariae radix showing immune enhancing activity and the use thereby
08/12/2010WO2010089940A1 Mucosal vaccine
08/12/2010WO2010089510A2 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
08/12/2010WO2010089355A1 Taurine or taurine-like substances for the prevention and treatment of a disease associated with retinal ganglion cell degeneration
08/12/2010WO2010088786A1 Herbal composition having cox-2 and immune activities and preparation method thereof
08/12/2010WO2010054126A3 Small molecule modulators of epigenetic regulation and their therapeutic applications
08/12/2010WO2010045199A3 Method of modulating ship activity
08/12/2010US20100204322 Method of treating autoimmune diseases
08/12/2010US20100204295 Treatment of allergic disease with immunomodulator compounds
08/12/2010US20100204274 Piperidinyl derivatives as modulators of chemokine receptor activity
08/12/2010US20100204250 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
08/12/2010US20100204241 New pyridazin-3(2h)-one derivatives
08/12/2010US20100204222 Pyridopyrimidine derivatives as p13 kinase inhibitors
08/12/2010US20100204219 Aromatic 1,4-di-carboxylamides and their use
08/12/2010US20100204213 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
08/12/2010US20100204208 Protein kinase c inhibitors and uses thereof
08/12/2010US20100204203 Chemical Compounds 637: Pyridopyrimidinediones as PDE4 Inhibitors
08/12/2010US20100204198 Hydrogenated benzo (c) thiophene derivatives as immunomodulators
08/12/2010US20100204191 Function-Selective Vitamin D Receptor Agonist
08/12/2010US20100204187 Purine Derivatives
08/12/2010US20100204184 Phosphonates useful as modulators of T-gamma-9-delta-2 activity
08/12/2010US20100204182 Ectonucleotidase inhibitors
08/12/2010US20100204170 Heterobifunctional pan-selectin inhibitors
08/12/2010US20100204158 Combination of splenopentin and thymopentin and the use thereof in medicine
08/12/2010US20100204157 Use of a peptide as a therapeutic agent
08/12/2010US20100204153 Use of band 3 protein (824-829) and/or melanocyte-stimulating hormone release-inhibiting factor as a therapeutic agent in the treatment of pseudomonas aeruginosa infection
08/12/2010US20100204152 Use of gluten exorphin c : as a therapeutic agent
08/12/2010US20100204151 Use of a peptide as a therapeutic agent
08/12/2010US20100204149 Use of octreotide as a therapeutic agent
08/12/2010US20100204148 (d-leu7 ) -histrelin as a therapeutic agent
08/12/2010US20100204145 Use of a peptide as a therapeutic agent
08/12/2010US20100204144 Use of the peptides maippkknqdk (cow kappa casein 106-116) and/or ygfqna (serorphin) as therapeutic agents
08/12/2010US20100204142 Use of the peptide phpfhlfvy (renin inhibitor) as a therapeutic agent
08/12/2010US20100204141 Use of bpp-b as a therapeutic agent
08/12/2010US20100204138 Use of trp6-triptorelin and d-leu6-leuprolide as therapeutic agents
08/12/2010US20100204136 Use of a peptide as a therapeutic agent
08/12/2010US20100204135 Use of lvv-hemorphin-6 and optionally af12198 as therapeutic agent(s)
08/12/2010US20100204132 THERAPEUTIC USES OF PEPTIDES YSAYPDSVPMMS and WMNSTGFTKVCGAPPC
08/12/2010US20100204131 Use of a peptide as a therapeutic agent
08/12/2010US20100204117 Cgrp as a therapeutic agent
08/12/2010US20100204116 Use of calcitonin as anti-angiogenic agent
08/12/2010US20100204115 Use of acetyl- (ala10, 11)-rantes (1-14) and/or calcitonin as anti-angiogenic agents
08/12/2010US20100204114 Use of a galanin peptide as a therapeutic agent
08/12/2010US20100204113 Use of stresscopin-related peptide as a therapeutic agent
08/12/2010US20100204112 Use of tyr-w-mif-1 and urocortin 2 as therapeutic agents
08/12/2010US20100204111 Astressin and beta- endorphin for use as therapeutic agents
08/12/2010US20100204110 Use of a peptide as a therapeutic agent
08/12/2010US20100204109 Use of c-type natriuretic peptide, alone or in combination with neuropeptide af, as a therapeutic agent
08/12/2010US20100204107 Use of urodilatin as a therapeutic agent
08/12/2010US20100204096 Treatment of inflammation, demyelination and neuronal/axonal loss
08/12/2010US20100203628 Novel modified galectin 9 proteins and use thereof
08/12/2010US20100203542 Method for treating autoimmune diseases and screening method for preventive or therapeutic agent for the same
08/12/2010US20100203153 Sustained-release nanoparticle compositions and methods using the same
08/12/2010US20100203120 Pharmaceutical cyclosporin compositions
08/12/2010US20100203089 Selective chemokine modulation
08/12/2010US20100203085 Toxoplasma Gondii Vaccines and Uses Thereof
08/12/2010US20100203083 Mutated structural protein of a parvovirus
08/12/2010US20100203082 Virus-modified bacteria ghosts
08/12/2010US20100203081 Viral inhibitory nucleotide sequences and vaccines
08/12/2010US20100203070 Contiguous Overlapping Peptides for Treatment of Birch Pollen Allergy
08/12/2010US20100203059 Method of treating a pathological syndrome and a pharmaceutical agent
08/12/2010US20100203053 Method and composition for treating immune complex associated disorders
08/12/2010US20100203049 Interleukin-10 Antibodies
08/12/2010US20100203042 Recombinant anti-vla4 antibody molecules
08/12/2010US20100203041 Antibodies to egfl7 and methods for their use
08/12/2010US20100203039 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
08/12/2010US20100203012 Iap bir domain binding compounds
08/12/2010US20100203009 Pathway for Th-17 Cell Development and Methods Utilizing Same
08/12/2010US20100203008 Novel compositions for the treatment of verious inflammatory conditions
08/12/2010CA2751481A1 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
1 ... 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 ... 1172